Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...

Ketamine has promise as a potential treatment for bipolar depression, particularly for people whose condition hasn’t ...

Through Colorado’s Path4EMS program, a mental health clinic reduces ketamine infusion costs from $400 to $150, making treatment more accessible for first responders ...

Pharmacology and Neurobiological Mechanisms of Action Ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, has emerged as a promising treatment for TRD. Originally an ...

Ketamine has been around for decades but has been having a resurgence in recent years as an option for people with treatment-resistant depression. Loosened regulations around remote prescriptions ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders. But the drug does ...